Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. (2023)

First Author: Saner FAM
Attributed to:  Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.11.09.23298321

PubMed Identifier: 37986741

Publication URI: http://europepmc.org/abstract/MED/37986741

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences